Form 4: MapLight Therapeutics Executive Sells Shares
Insider Transaction (Form 4)
Erin Pennock Foff, Chief Medical Officer of MapLight Therapeutics, Inc., sold 47,158 shares of common stock on July 15, 2026.
Summary
- Open-market sale: disposed of 7,155 Voting Common Stock at $36.16 ($258,725) on July 15, 2026; holds 338,904 after (Direct).
- Open-market sale: disposed of 7,845 Voting Common Stock at $37.04 ($290,579) on July 15, 2026; holds 331,059 after (Direct).
- Open-market sale: disposed of 4,465 Voting Common Stock at $36.00 ($160,740) on July 15, 2026; holds 326,594 after (Direct).
- Open-market sale: disposed of 8,972 Voting Common Stock at $36.99 ($331,874) on July 15, 2026; holds 317,622 after (Direct).
- Open-market sale: disposed of 18 Voting Common Stock at $37.54 ($676) on July 15, 2026; holds 317,604 after (Direct).
- Open-market sale: disposed of 9,163 Voting Common Stock at $36.46 ($334,083) on July 16, 2026; holds 308,441 after (Direct).
- Open-market sale: disposed of 5,865 Voting Common Stock at $37.26 ($218,530) on July 16, 2026; holds 302,576 after (Direct).
- Open-market sale: disposed of 19 Voting Common Stock at $37.96 ($721) on July 16, 2026; holds 302,557 after (Direct).
- Open-market sale: disposed of 3,656 Voting Common Stock at $37.90 ($138,562) on July 17, 2026; holds 298,901 after (Direct).
Sentiment
Score: 4
Explanation: StockSavvy.ai views this as a mildly negative but low-conviction signal: an insider sold $1,734,490 of stock under a pre-arranged Rule 10b5-1 plan, which is typically routine.
Insider Transactions
Erin Pennock Foff — Officer (Chief Medical Officer)
Transaction made under a Rule 10b5-1 trading plan.
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-07-15 | Open-market sale | Voting Common Stock | 7,155 | $36 | $258.7K | 338,904 |
| 2026-07-15 | Open-market sale | Voting Common Stock | 7,845 | $37 | $290.6K | 331,059 |
| 2026-07-15 | Open-market sale | Voting Common Stock | 4,465 | $36 | $160.7K | 326,594 |
| 2026-07-15 | Open-market sale | Voting Common Stock | 8,972 | $37 | $331.9K | 317,622 |
| 2026-07-15 | Open-market sale | Voting Common Stock | 18 | $38 | $676 | 317,604 |
| 2026-07-16 | Open-market sale | Voting Common Stock | 9,163 | $36 | $334.1K | 308,441 |
| 2026-07-16 | Open-market sale | Voting Common Stock | 5,865 | $37 | $218.5K | 302,576 |
| 2026-07-16 | Open-market sale | Voting Common Stock | 19 | $38 | $721 | 302,557 |
| 2026-07-17 | Open-market sale | Voting Common Stock | 3,656 | $38 | $138.6K | 298,901 |
Key Dates
| Date | Description |
|---|---|
| 2026-07-15 | Open-market sale (7,155 shares) |
| 2026-07-15 | Open-market sale (7,845 shares) |
| 2026-07-15 | Open-market sale (4,465 shares) |
| 2026-07-15 | Open-market sale (8,972 shares) |
| 2026-07-15 | Open-market sale (18 shares) |
| 2026-07-16 | Open-market sale (9,163 shares) |
| 2026-07-16 | Open-market sale (5,865 shares) |
| 2026-07-16 | Open-market sale (19 shares) |
| 2026-07-17 | Open-market sale (3,656 shares) |
Keywords
insider transaction, Form 4, MPLT, MapLight Therapeutics, Inc., bearish, Erin Pennock Foff
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.